International guidelines regarding the role of intravenous immunoglobulin in the management of RhD- and ABO-mediated haemolytic disease of the newborn-reconsidering the recommendations.
Autor: | Hansen TWR; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Akkök CA; Section of Immunohematology, Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway., Watchko JF; Division of Newborn Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | British journal of haematology [Br J Haematol] 2022 Nov; Vol. 199 (3), pp. 452-453. Date of Electronic Publication: 2022 Aug 22. |
DOI: | 10.1111/bjh.18421 |
Databáze: | MEDLINE |
Externí odkaz: |